Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05304104 · ClinicalTrials.gov registry record · NA

Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans

A NA study of Binge-Eating Disorder and Bulimia Nervosa, sponsored by VA Connecticut Healthcare System.

Recruiting
Registry status
NA
Development phase
144
Enrollment target
1
Study location

NCT05304104: Recruiting NA study of Binge-Eating Disorder and Bulimia Nervosa, sponsored by VA Connecticut Healthcare System.

NCT05304104 is a NA study of Binge-Eating Disorder and Bulimia Nervosa that is actively recruiting participants, run by VA Connecticut Healthcare System. The registered enrollment target is 144 participants, below the 1,140-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05304104, a NA study of Binge-Eating Disorder and Bulimia Nervosa, is actively recruiting participants, sponsored by VA Connecticut Healthcare System.

RECRUITING
Registry status
NA
Development phase
144 participants
Enrollment target
1
Study location

Study Summary

When untreated, eating disorders present with tremendous burdens to affected active duty Service members and Veterans and their families, and are very costly to the DoD and VA healthcare system. A comparative effectiveness study with state-of-the-art virtual treatment for BN and BED specifically adapted for testing with the Veteran population and other underrepresented eating disorder populations will lead to major improvements in clinical outcomes. The treatment will be integrated with VA's newest telehealth technology to profoundly enhance access to care anywhere, at any time. This trial of therapist-led and self-help CBT treatments, combined with our expert panel methods to inform VA Clinical Practice Guidelines for Eating Disorders and plans for dissemination, will accelerate the pace for the transition of results both for large-scale deployment in the VA system and for real-world impact among diverse and underrepresented eating disorder populations.

Primary Outcome

The EDE is the structured diagnostic interview that is considered the gold-standard to diagnose, and assess the symptoms of, eating disorders including binge eating, purging behaviors, and eating disorder pathology.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)

Study Locations (1)

Connecticut

  • VA Connecticut Healthcare System - West Haven

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2022-04-22
Est. Completion 2025-12
Phase NA
VA Connecticut Healthcare System

26 total trials

What NCT05304104 shows while recruiting

NCT05304104 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,140-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (87% lower).

The record links to 4 conditions, with Binge-Eating Disorder appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT05304104 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT05304104 about?

NCT05304104 is a clinical study titled "Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans". When untreated, eating disorders present with tremendous burdens to affected active duty Service members and Veterans and their families, and are very costly to the DoD and VA healthcare system. A comparative effectiveness study with state-of-the-art virtual treatment for BN and BED specifically ada...

What is the current status of trial NCT05304104?

This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2022-04-22. Estimated completion is 2025-12.

What conditions does trial NCT05304104 study?

This clinical trial studies the following conditions: Binge-Eating Disorder, Bulimia Nervosa, Cognitive Behavioral Therapy, Veterans Health.

What interventions are being tested in trial NCT05304104?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05304104?

This trial is sponsored by VA Connecticut Healthcare System, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05304104 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Binge-Eating Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05304104's enrollment target sits among peer trials

144 10th of 37 higher than 28 of 37 other Binge-Eating Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05304104, the US trial registry maintained by the National Library of Medicine. NCT05304104 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.